Purchase Order 75N91018P00311

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $11,440 on March 8, 2018, with completion by March 27, 2019. Work is performed in Bethesda, Maryland. The order is firm fixed price with no set-aside applied. Specific scope of supply is not detailed in the award record.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on August 8, 2019, with a ceiling value of $18,641.70 for firm fixed price procurement. The place of performance is Bethesda, Maryland 20814. No set-aside category was applied. The order ultimate completion date is August 7, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on June 27, 2018, with a ceiling value of $7,422.68. The order, issued under firm fixed pricing, calls for delivery to Bethesda, Maryland, with an ultimate completion date of July 8, 2019. No set-aside was applied.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $14,350 on December 5, 2019, for a service agreement covering scientific equipment. Place of performance is Bethesda, Maryland. The order carries a firm fixed price and has an ultimate completion date of December 2, 2020. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $24,441.58 on April 24, 2018, to supply laboratory supplies. The order carries no small business set-aside. Performance occurs in Marlborough, Massachusetts. Ultimate completion is May 23, 2018. The contract uses firm fixed price terms.</p>

The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC valued at $17,871.00 on February 1, 2018, with an ultimate completion date of January 31, 2019. The order carries fixed-price pricing with economic price adjustment and covers scientific equipment and consumables to be delivered to Bethesda, Maryland. Global Life Sciences Solutions is a wholly owned subsidiary of Danaher Corporation and competes full-and-open without small business set-asides.

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on June 7, 2018, with a ceiling value of $4,300.08 and ultimate completion date of June 14, 2019. The order is priced as firm fixed price with no set-aside. Place of performance is Marlborough, Massachusetts. The specific procurement details and commodity description are not provided in the source material.</p>

<p>The National Cancer Institute issued a delivery order to Government Scientific Source Inc. on May 23, 2018, with a ceiling value of $4,123.65 under the GSA Schedule Scientific Equipment and Services (FSS-66).</p> <p>Place of performance is Bethesda, MD 20892. The order was issued as Firm Fixed Price with no set-aside. Ultimate completion date is June 23, 2018.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $4,470.04 on April 6, 2018, with completion on June 22, 2019. Work was performed in Bethesda, Maryland. The order carried firm fixed price and no set-aside designation. The source does not specify the items or services procured.</p>